Latigo Biotherapeutics Inc

LTGONASDAQ
$22.48
0.713.26%
At close: Sep 3, 5:00 PM EST
$22.48
N/A
After Hours: 4:00 PM EST
Earnings: Q2 2026 Earnings were released on Thu Sep 3rd, after the market close

Latigo Biotherapeutics Ownership & Insider Activity

Latigo Biotherapeutics (LTGO) institutional and insider ownership, recent insider transactions and ownership breakdown.

Shares Outstanding

63.238M

Net Insider Activity by Month

Purchases (90d)

2

$5.0M total

Sales (90d)

0

Net Activity

Net Buying

Net Value (90d)

$5.0M

Latigo Biotherapeutics Insider Transactions (Last 6 Months)

See all insider trades
DateInsiderTitleTypeSharesPriceValue
Aug 10, 2026Foresite Capital Management V LLC, Foresite Capital Fund V LP, Foresite Capital Opportunity Management V LLC, Foresite Capital Opportunity Fund V LP, Foresite Capital Management VI LLC, Foresite Capital Fund VI LP10% OWNERBUY9.181M$18.00$2.5M
Aug 10, 2026James TananbaumBUY9.181M$18.00$2.5M